Global Leading Market Research Publisher QYResearch announces the release of its latest report “Medical Disposable Endobag – Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032”. This comprehensive study delivers an authoritative analysis of the global medical disposable endobag market, integrating historical impact data (2021-2025) with forward-looking forecast calculations (2026-2032). Covering critical dimensions such as market size, market share, demand trajectories, industry development status, and long-term growth projections, this report serves as an essential strategic resource for stakeholders across minimally invasive surgery, operating room management, surgical device manufacturing, and infection prevention sectors.
For laparoscopic surgeons, operating room directors, and healthcare facility administrators confronting the critical challenge of removing tissue specimens during minimally invasive procedures without contaminating surrounding tissues or risking port site seeding—medical disposable endobags represent the essential single-use device that enables safe, contained specimen retrieval. Traditional methods of specimen extraction through laparoscopic incisions risk tissue fragmentation, contamination of the abdominal cavity, and potential tumor seeding along the extraction tract. Medical disposable endobags address these risks through sterile, single-use retrieval pouches that contain specimens securely during extraction—preventing tissue contact with the abdominal wall, containing infectious or malignant material, and enabling complete specimen removal for pathological analysis—all while maintaining the benefits of minimally invasive surgical approaches.
Market Growth Outlook: A US$159 Million Opportunity at 3.7% CAGR
The global medical disposable endobag market demonstrated stable growth fundamentals in 2025, with total market value estimated at US$ 124 million. According to QYResearch’s latest industry analysis, this figure is projected to expand to US$ 159 million by 2032, representing a steady compound annual growth rate (CAGR) of 3.7% over the forecast period. In volume terms, global production reached approximately 9,417,000 units in 2024, with average unit pricing of US$ 12. This sustained growth trajectory reflects the continued expansion of minimally invasive surgical procedures, increasing emphasis on infection prevention and specimen containment, and ongoing adoption of laparoscopic techniques across surgical specialties.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/6093866/medical-disposable-endobag
Product Definition: Specimen Retrieval for Minimally Invasive Surgery
A medical disposable endobag—also referred to as a specimen retrieval bag or laparoscopic retrieval pouch—is a single-use medical device specifically designed for use in minimally invasive (laparoscopic) surgeries to safely remove tissue specimens from the abdominal cavity. These devices enable surgeons to contain specimens—including gallbladders, appendices, tumors, and other excised tissues—within a sterile pouch during extraction, preventing contamination of surrounding tissues and maintaining the integrity of the specimen for pathological examination.
Device Architecture and Design Features:
Bag Construction:
- Material: Transparent, flexible polymer (typically polyurethane or nylon) with high tensile strength
- Reinforced rim: Structural support for opening and manipulation
- Sealed seams: Leak-proof construction preventing fluid or tissue escape
- Radiopaque markers: X-ray visibility for postoperative identification if retained
Deployment Mechanism:
- Rolled configuration: Compact deployment through trocar ports
- Opening mechanism: Pre-shaped rim or pull-string design for controlled opening
- Manipulation: Ability to position and orient within the surgical field
- Retrieval: Drawstring closure for secure containment during extraction
Size Configurations:
Small (100–300 mL):
- Applications: Gallbladder; appendix; small tissue specimens
- Procedures: Laparoscopic cholecystectomy; appendectomy; diagnostic biopsies
- Port size compatibility: 5–10 mm trocars
Medium (500–1000 mL):
- Applications: Ovarian cysts; renal specimens; moderate-sized tumors
- Procedures: Laparoscopic ovarian cystectomy; nephrectomy; colectomy
- Port size compatibility: 10–12 mm trocars
Large (1200–2000 mL):
- Applications: Large tumors; splenic specimens; multiple specimen collections
- Procedures: Laparoscopic splenectomy; oncologic resections; morcellation containment
- Port size compatibility: 12–15 mm trocars
Clinical Applications:
General Surgery:
- Cholecystectomy: Gallbladder removal and retrieval
- Appendectomy: Appendix containment and extraction
- Colectomy: Colonic specimen retrieval
- Hernia repair: Mesh or tissue specimen containment
Gynecologic Surgery:
- Ovarian cystectomy: Cyst and tissue specimen retrieval
- Hysterectomy: Uterine specimen containment
- Myomectomy: Fibroid tissue removal
Urologic Surgery:
- Nephrectomy: Kidney specimen retrieval
- Adrenalectomy: Adrenal gland removal
- Prostatectomy: Prostate tissue containment
Oncologic Surgery:
- Tumor resection: Malignant tissue containment
- Morcellation: Contained tissue fragmentation
- Lymph node dissection: Node specimen retrieval
Market Drivers and Structural Trends
Minimally Invasive Surgery Expansion:
The global shift toward minimally invasive surgical approaches drives market growth:
- Laparoscopic procedures: Standard of care for many surgical indications
- Robotic surgery: Expanding platform for minimally invasive approaches
- Single-incision surgery: Enhanced visualization requirements
- Outpatient surgery: Same-day discharge with reduced complications
Infection Prevention and Patient Safety:
Endobags contribute to infection prevention through:
- Containment: Preventing tissue contact with abdominal wall
- Sealed extraction: No spillage during retrieval
- Sterile technique: Single-use device maintaining sterility
- Port site protection: Reducing risk of surgical site infection
Oncologic Considerations:
For malignant specimens, endobags provide critical containment:
- Port site seeding prevention: Containing malignant cells during extraction
- Complete specimen retrieval: Ensuring adequate margins for pathological evaluation
- Morcellation containment: Contained tissue fragmentation for larger specimens
- Safety protocols: Adherence to oncologic surgical principles
Procedure Volume Growth:
Surgical procedure volumes continue to increase:
- Aging population: Increased surgical indications
- Obesity prevalence: Higher rates of cholecystectomy and other procedures
- Cancer incidence: Growing oncologic surgical caseload
- Screening programs: Earlier detection driving surgical intervention
Segment Analysis and Market Dynamics
Segment by Capacity:
- Small (100–300 mL): Largest segment; high-volume procedures (cholecystectomy, appendectomy)
- Medium (500–1000 mL): Growing segment; gynecologic and urologic procedures
- Large (1200–2000 mL): Specialized segment; oncologic and complex resections; higher per-unit value
Segment by End User:
- Hospital: Largest segment; surgical volume; operating room procedures; established utilization
- Clinic: Ambulatory surgery centers; outpatient procedures; growing adoption
Competitive Landscape: Key Manufacturers
The global medical disposable endobag market features specialized surgical device manufacturers with minimally invasive surgery expertise. Key manufacturers profiled in the report include:
Global Leaders:
- B. Braun Medical
- Stapleline Medizintechnik
- Unimicro Medical Systems
- Enmind Technology
- Asid Bonz
- Sinolinks Medical
- Mindray
- Geyi Medical
Specialized and Regional Manufacturers:
- Segimedical
- Kangji
- Zhonglin Medical
- Dechuan Medical Instrument
- Guanchuang Medical
- Coopwinmed
- Yingtai Medical Tech
- Celtics MediTech
- GENICON
- Purple Surgical
- Lantex Medical
Strategic Outlook and Exclusive Market Insights
The Specimen Containment Paradigm:
From an industry analyst’s perspective, the medical disposable endobag market is positioned at the intersection of surgical technique and infection prevention. The shift from open to laparoscopic surgery created the need for contained specimen retrieval; the increasing complexity of laparoscopic procedures drives demand for more sophisticated endobag designs; and growing awareness of port site seeding risks in oncologic surgery reinforces the value of reliable specimen containment.
Size Segmentation and Procedure Correlation:
Endobag size selection correlates directly with procedure type and specimen characteristics:
- Small bags: High-volume general surgery (gallbladder, appendix)
- Medium bags: Gynecologic and urologic procedures (ovarian cysts, renal specimens)
- Large bags: Oncologic resections and morcellation procedures
Understanding this correlation enables manufacturers to align product development with procedure volume trends.
The Morcellation Controversy and Contained Morcellation:
The FDA’s 2014 safety communication regarding laparoscopic power morcellation in myomectomy and hysterectomy created significant market impact:
- Safety concerns: Risk of occult uterine sarcoma dissemination
- Contained morcellation: Endobags used for contained tissue fragmentation
- Technique adoption: Growing utilization of morcellation within containment systems
- Device development: Specialized endobags with enhanced strength for morcellation
This clinical context has driven demand for larger, more robust endobags designed for contained morcellation.
Geographic Market Dynamics:
- North America: Largest market; high laparoscopic procedure volumes; strong infection prevention focus; regulatory oversight
- Europe: Advanced market; established minimally invasive surgery programs; growing outpatient procedure volume
- Asia-Pacific: Fastest-growing region; expanding surgical capacity; increasing adoption of laparoscopic techniques; China, India, Japan as growth markets
- Emerging Markets: Growing healthcare infrastructure; increasing surgical volume; price sensitivity
Future Technology Trajectories:
The medical disposable endobag market will be shaped by:
- Enhanced materials: Increased tear resistance for larger specimens
- Integrated features: Specimen measurement; visualization enhancement
- Robotic compatibility: Designs optimized for robotic surgical platforms
- Sustainable materials: Biodegradable polymers; environmental considerations
- Cost optimization: Value-based procurement for high-volume procedures
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
